EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

ALPPS VS PVE VS LVD: selecting the optimal liver hypertrophy method for patients with liver malignancies, before undergoing large scale hepatectomy; A systematic review and meta-analysis

Afroditi Fotiadou, Kyriacos Evangelou, Nikolaos Arkadopoulos, Ioannis Hatzaras

HPB · 2026

DOI: 10.1016/j.hpb.2026.04.464 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift HPB, 2026. Verfasst von Afroditi Fotiadou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece; Department of General, Visceral and Transplantation Surgery, Univ…. Hauptthemen laut MEDLINE: Hepatectomy, Portal Vein, Liver Neoplasms, Embolization, Therapeutic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Large scale hepatectomy for primary or metastatic liver tumors may be limited by insufficient Future Liver Remnant (FLR). Strategies to enhance FLR hypertrophy include associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), portal vein embolization (PVE), and Liver Venous Deprivation (LVD). Their comparative efficacy in the context of open hepatectomy remains unclear. METHODS: A systematic review and meta-analysis of pairwise comparative studies was conducted (PubMed, Embase, Scopus, Cochrane). Risk of bias was assessed using ROBINS-I. Random-effects models were applied, with p < 0.05 considered significant. RESULTS: 24 retrospective cohort studies with a total of 1263 patients were included, with 1/3 judged as moderate and the rest as severe overall risk of bias. ALPPS induced higher mean Kinetic Growth Rate (KGR) than PVE (SMD = 1.61; 95%CI = 1.23,1.99; p < 0.01) and LVD (ROM = 3.15; 95%CI = 2.66,3.71, p < 0.01), and LVD than PVE (ROM = 1.96; 95%CI = 1.75,2.22; p < 0.01). ALPPS was associated with superior hepatectomy completion rates compared to PVE (OR = 13.75; 95%CI = 3.24,58.57; p < 0.01), and worse 1-year DFS (OR = 0.45; 95%CI = 0.21,0.93; p = 0.03). The rest of the comparisons failed to reach statistical significance. CONCLUSION: ALPPS seems to induce the most rapid FLR hypertrophy, but no substantial differences regarding postoperative outcomes were observed. Further, ideally randomised, studies are necessary to draw clear and clinically relevant conclusions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatectomyPortal VeinLiver NeoplasmsEmbolization, TherapeuticLiver RegenerationLiverHumansLigationTreatment OutcomeRisk FactorsTime FactorsHypertrophy

Autor:innen und Institutionen

  • Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece; Department of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Heidelberg, Germany. Electronic address…
  • School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • 4th Surgical Department, "Attikon" University General Hospital of Athens, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Zitieren

APA

Fotiadou, A., Evangelou, K., Arkadopoulos, N., & Hatzaras, I. (2026). ALPPS VS PVE VS LVD: selecting the optimal liver hypertrophy method for patients with liver malignancies, before undergoing large scale hepatectomy; A systematic review and meta-analysis. HPB. https://doi.org/10.1016/j.hpb.2026.04.464

Vancouver

Fotiadou A, Evangelou K, Arkadopoulos N, Hatzaras I. ALPPS VS PVE VS LVD: selecting the optimal liver hypertrophy method for patients with liver malignancies, before undergoing large scale hepatectomy; A systematic review and meta-analysis. HPB. 2026. doi:10.1016/j.hpb.2026.04.464

BibTeX
@article{Fotiadou2026,
  author = {Fotiadou, Afroditi and Evangelou, Kyriacos and Arkadopoulos, Nikolaos and Hatzaras, Ioannis},
  title = {ALPPS VS PVE VS LVD: selecting the optimal liver hypertrophy method for patients with liver malignancies, before undergoing large scale hepatectomy; A systematic review and meta-analysis},
  journal = {HPB},
  year = {2026},
  doi = {10.1016/j.hpb.2026.04.464}
}
Kostenlos starten →